Latest news and press releases about NEXGEL, Inc. (NXGL): earnings reports, analyst upgrades/downgrades, product launches, partnerships and regulatory filings. Stay updated on every market-moving event.
NEXGEL, Inc. is a company that develops and produces advanced hydrogels and gels. These materials are characterized by their significant water content, aqueous polymer composition, and electron beam cross-linking technology. NEXGEL's diverse product range serves crucial applications across several sectors, including wound care management, medical diagnostic tools, transdermal drug delivery systems, and cosmetic formulations.
Price
| Price | $0.25 |
| Market Cap | $2M |
| Exchange | NASDAQ |
| Country | US |
Valuation Ratios
| Price / Book | 0.45 |
| EV / EBITDA | -4.57 |
| Dividend Yield | 0.00% |
Profitability
| Return on Equity | -133.10% |
| Return on Invested Capital | -41.80% |
| Return on Assets | -23.39% |
| Gross Margin | 35.07% |
| Operating Margin | -44.77% |
| Net Margin | -51.26% |
Related companies: ENLV · FEMY · GDTC · HBIO · IINN · MLSS · MTVA
Explore sector: Healthcare · Medical - Instruments & Supplies
More sections of NXGL: Overview · Financials · Valuation · Statistics · Estimates · Technical · Ownership · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks